Hikma Pharmaceutical | HIK - Current Assets


Hikma Pharmaceutical reported $2.64B in Current Assets for its fiscal semester ending in December of 2025.





Current Assets Change Date
Almirall EUR 713.98M 69K Dec/2025
argenx SE USD 6.9B 1.07B Dec/2025
AstraZeneca USD 29.61B 890M Mar/2026
Autolus Therapeutics Ltd USD 368.84M 67.08M Mar/2026
Bayer EUR 35.3B 2.39B Mar/2026
Fresenius EUR 11.03B 1.03B Dec/2025
Genmab DKK 2.88B 1.59B Dec/2025
GlaxoSmithKline GBP 17.76B 251M Mar/2026
GRIFOLS EUR 5.25B 180M Mar/2026
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
Lakefront Biotherapeutics EUR 3.06B 18.72M Mar/2026
Lonza CHF 8B 3.41B Dec/2025
Merck EUR 14.16B 932M Mar/2026
Orion EUR 1.41B 66.8M Mar/2026
Recordati EUR 1.73B 50.28M Mar/2026
Roche Holding CHF 38.73B 3.03B Dec/2025
Sanofi EUR 30.16B 789M Mar/2026
UCB EUR 6.05B 733M Dec/2025